These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Expanding the phenotype of GMPPB mutations. Cabrera-Serrano M; Ghaoui R; Ravenscroft G; Johnsen RD; Davis MR; Corbett A; Reddel S; Sue CM; Liang C; Waddell LB; Kaur S; Lek M; North KN; MacArthur DG; Lamont PJ; Clarke NF; Laing NG Brain; 2015 Apr; 138(Pt 4):836-44. PubMed ID: 25681410 [TBL] [Abstract][Full Text] [Related]
9. Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review. Sun L; Shen D; Xiong T; Zhou Z; Lu X; Cui F Bosn J Basic Med Sci; 2020 May; 20(2):275-280. PubMed ID: 30684953 [TBL] [Abstract][Full Text] [Related]
10. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662 [TBL] [Abstract][Full Text] [Related]
11. Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome. Bobadilla-Quesada EJ; Natera-de Benito D; Carrera-García L; Ortez C; Exposito-Escudero J; Jimenez-Mallebrera C; Jou C; Codina A; Corbera J; Moya O; Saez V; Gonzalez-Quereda L; Gallano P; Colomer J; Cuadras D; Medina J; Yoldi ME; Nascimento A Neuromuscul Disord; 2020 Sep; 30(9):719-726. PubMed ID: 32819792 [TBL] [Abstract][Full Text] [Related]
13. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512 [TBL] [Abstract][Full Text] [Related]
14. Distinct and Recognisable Muscle MRI Pattern in a Series of Adults Harbouring an Identical GMPPB Gene Mutation. Siddiqui S; Polavarapu K; Bardhan M; Preethish-Kumar V; Joshi A; Nashi S; Vengalil S; Raju S; Chawla T; Leena S; Mathur A; Nayak S; Mohan D; Shamim U; Prasad C; Lochmüller H; Faruq M; Nalini A J Neuromuscul Dis; 2022; 9(1):95-109. PubMed ID: 34633329 [TBL] [Abstract][Full Text] [Related]
15. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies. Løkken N; Born AP; Duno M; Vissing J Muscle Nerve; 2015 Oct; 52(4):547-53. PubMed ID: 25663498 [TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness. Lorenzoni PJ; Kay CSK; Arndt RC; Hrysay NMC; Ducci RD; Fustes OHJ; Töpf A; Lochmüller H; Werneck LC; Scola RH J Clin Neurosci; 2020 May; 75():195-198. PubMed ID: 32238315 [TBL] [Abstract][Full Text] [Related]
17. Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review. Luan X; Tian W; Cao L Clin Neurol Neurosurg; 2016 Nov; 150():41-45. PubMed ID: 27588369 [TBL] [Abstract][Full Text] [Related]
18. Mobility shift of beta-dystroglycan as a marker of Sarkozy A; Torelli S; Mein R; Henderson M; Phadke R; Feng L; Sewry C; Ala P; Yau M; Bertoli M; Willis T; Hammans S; Manzur A; Sframeli M; Norwood F; Rakowicz W; Radunovic A; Vaidya SS; Parton M; Walker M; Marino S; Offiah C; Farrugia ME; Mamutse G; Marini-Bettolo C; Wraige E; Beeson D; Lochmüller H; Straub V; Bushby K; Barresi R; Muntoni F J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):762-768. PubMed ID: 29437916 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of the myasthenic syndrome arising from mutations in GMPPB. Rodríguez Cruz PM; Belaya K; Basiri K; Sedghi M; Farrugia ME; Holton JL; Liu WW; Maxwell S; Petty R; Walls TJ; Kennett R; Pitt M; Sarkozy A; Parton M; Lochmüller H; Muntoni F; Palace J; Beeson D J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):802-9. PubMed ID: 27147698 [TBL] [Abstract][Full Text] [Related]